{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:43:17Z","timestamp":1788212597794,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.idcr.2022.e01451","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T03:30:41Z","timestamp":1644636641000},"page":"e01451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Helicobacter pylori infection manifesting as Hypereosinophilic syndrome and immune thrombocytopenia complicated by portal vein thrombosis and ischemic colitis"],"prefix":"10.1016","volume":"27","author":[{"given":"Awni","family":"Alshurafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Sied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maab","family":"Elkhdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Abdalhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idcr.2022.e01451_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.idcr.2022.e01451_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2006.06038.x","article-title":"Eosinophilia: secondary, clonal and idiopathic","volume":"133","author":"Tefferi","year":"2006","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.idcr.2022.e01451_bib3","article-title":"Clinical outcome of eosinophilia in patients with COVID-19: a controlled study","volume":"91","author":"Nair","year":"2020","journal-title":"Acta Bio-Med Atenei Parm"},{"key":"10.1016\/j.idcr.2022.e01451_bib4","doi-asserted-by":"crossref","unstructured":"Mangal. Helicobacter pylori infection presenting as a hypereosinophilic syndrome and secondary immune thrombocytopenia. Accessed June 22, 2021. \u3008https:\/\/www.jahjournal.org\/article.asp?issn=1658\u20135127;year=2020;volume=11;issue=3;spage=141;epage=144;aulast=Mangal\u3009.","DOI":"10.4103\/joah.joah_44_20"},{"issue":"11","key":"10.1016\/j.idcr.2022.e01451_bib5","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.idcr.2022.e01451_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.2009.01247.x","article-title":"The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review","volume":"83","author":"Abrahamson","year":"2009","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.idcr.2022.e01451_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.idcr.2022.e01451_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bjhh.2017.09.005","article-title":"Platelet count response to Helicobacter pylori eradication for idiopathic thrombocytopenic purpura in northeastern Brazil","volume":"40","author":"Barbosa","year":"2018","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.idcr.2022.e01451_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.598846","article-title":"Prevalence of venous thromboembolism in critically Ill COVID-19 patients: systematic review and meta-analysis","volume":"7","author":"Mohamed","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.idcr.2022.e01451_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.iac.2007.07.001","article-title":"Cardiovascular manifestations of hypereosinophilic syndromes","volume":"27","author":"Ogbogu","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.idcr.2022.e01451_bib11","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1038\/s41598-020-65128-4","article-title":"Hypereosinophilia with concurrent venous thromboembolism: clinical features, potential risk factors, and short-term outcomes in a Chinese cohort","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.idcr.2022.e01451_bib12","doi-asserted-by":"crossref","first-page":"AB122","DOI":"10.1016\/j.jaci.2012.12.1105","article-title":"Hypereosinophilic syndrome and thrombosis: a retrospective review","volume":"131","author":"Wallace","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.idcr.2022.e01451_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1172-2-37","article-title":"Hypereosinophilic syndromes","volume":"2","author":"Roufosse","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.idcr.2022.e01451_bib14","unstructured":"Current Concepts on the pathogenesis of the hypereosinophilic syndrome\/chronic eosinophilic leukemia. Accessed June 24, 2021. \u3008https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3642145\/\u3009."},{"issue":"Suppl","key":"10.1016\/j.idcr.2022.e01451_bib15","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3347\/kjp.2009.47.S.S125","article-title":"Eosinophil-mediated tissue inflammatory responses in helminth infection","volume":"47","author":"Shin","year":"2009","journal-title":"Korean J Parasitol"},{"issue":"4","key":"10.1016\/j.idcr.2022.e01451_bib16","article-title":"Prevalence, clinical manifestations, and biochemical data of hypertensive versus normotensive symptomatic patients with COVID-19: a comparative study","volume":"91","author":"Iqbal","year":"2020","journal-title":"Acta Bio Med Atenei Parm"},{"issue":"3","key":"10.1016\/j.idcr.2022.e01451_bib17","article-title":"Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: a comparative study","volume":"91","author":"Soliman","year":"2020","journal-title":"Acta Bio-Med Atenei Parm"},{"issue":"3","key":"10.1016\/j.idcr.2022.e01451_bib18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3748\/wjg.v20.i3.714","article-title":"Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms","volume":"20","author":"Kuwana","year":"2014","journal-title":"World J Gastroenterol"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250922000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250922000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:04:05Z","timestamp":1761998645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250922000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":18,"alternative-id":["S2214250922000798"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2022.e01451","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helicobacter pylori infection manifesting as Hypereosinophilic syndrome and immune thrombocytopenia complicated by portal vein thrombosis and ischemic colitis","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2022.e01451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01451"}}